Financials American Oncology Network, Inc.
Equities
AONC
US0287191029
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.26 USD | -3.83% | -3.83% | -61.69% |
12:00am | American Oncology Network, Inc.(NasdaqCM:AONC) dropped from S&P TMI Index | CI |
06-07 | American Oncology Network, Inc.(OTCPK:AONC) dropped from NASDAQ Composite Index | CI |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 |
---|---|---|---|
Capitalization 1 | - | - | 56.35 |
Enterprise Value (EV) 1 | - | - | 125.3 |
P/E ratio | - | - | -4.32 x |
Yield | - | - | - |
Capitalization / Revenue | - | - | 0.04 x |
EV / Revenue | - | - | 0.04 x |
EV / EBITDA | - | - | -12.1 x |
EV / FCF | - | - | 2,949,166 x |
FCF Yield | - | - | 0% |
Price to Book | - | - | -0.35 x |
Nbr of stocks (in thousands) | - | - | 9,550 |
Reference price 2 | 9.750 | 10.04 | 5.900 |
Announcement Date | 06/01/23 | 28/04/23 | 28/03/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net sales 1 | 319.9 | 717.9 | 943.7 | 1,150 | 1,279 |
EBITDA 1 | 4.615 | 18.89 | 6.99 | 12.28 | -4.668 |
EBIT 1 | 3.607 | 15.23 | 0.911 | 5.566 | -13.12 |
Operating Margin | 1.13% | 2.12% | 0.1% | 0.48% | -1.03% |
Earnings before Tax (EBT) 1 | 2.528 | 21.17 | 0.355 | 2.589 | -35.69 |
Net income 1 | 2.773 | 21.95 | -0.105 | 2.589 | -5.542 |
Net margin | 0.87% | 3.06% | -0.01% | 0.23% | -0.43% |
EPS | - | - | - | - | -1.365 |
Free Cash Flow | - | - | -44.06 | -0.4669 | 19.11 |
FCF margin | - | - | -4.67% | -0.04% | 1.49% |
FCF Conversion (EBITDA) | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 06/01/23 | 06/01/23 | 06/01/23 | 28/04/23 | 28/03/24 |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net Debt | - | - | 36.3 | 92 | 68.9 |
Net Cash position | - | 6.34 | - | - | - |
Leverage (Debt/EBITDA) | - | - | 5.199 x | 7.486 x | -14.77 x |
Free Cash Flow | - | - | -44.1 | -0.47 | 19.1 |
ROE (net income / shareholders' equity) | - | - | -0.18% | 4.26% | -54.4% |
ROA (Net income/ Total Assets) | - | - | 0.25% | 1.21% | -2.34% |
Assets 1 | - | - | -41.42 | 213.8 | 236.8 |
Book Value Per Share | - | - | - | - | -17.00 |
Cash Flow per Share | - | - | - | - | 3.000 |
Capex 1 | 11.6 | 12.2 | 8.32 | 7.19 | 12.3 |
Capex / Sales | 3.63% | 1.7% | 0.88% | 0.63% | 0.96% |
Announcement Date | 06/01/23 | 06/01/23 | 06/01/23 | 28/04/23 | 28/03/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-61.69% | 14.9M | |
+24.25% | 88.08B | |
-24.01% | 75.32B | |
+3.45% | 28.19B | |
+6.59% | 17.78B | |
-13.14% | 16.64B | |
+2.09% | 15.64B | |
+79.55% | 13.81B | |
-26.67% | 13.01B | |
+21.81% | 12.43B |
- Stock Market
- Equities
- AONC Stock
- Financials American Oncology Network, Inc.